From the Journals

Different OSA subtypes respond differently to therapy

View on the News

Results underscore importance of personalized treatment

The results of these studies “advance the personalization of sleep apnea care by validating distinct symptom-based groups that generalize across nations and assessing how members of these clinical phenotypes respond to therapy,” wrote Vishesh K. Kapur, MD, of the division of pulmonary, critical care and sleep medicine at the University of Washington, Seattle, in an editorial published in the March issue of Sleep (2018 Mar. doi: 10.1093/sleep/zsy042).

“Patients with OSA differ in their presenting symptoms,” he said, and future studies should aim to “elucidate whether the proposed phenotypes will enable a more personalized paradigm of sleep apnea care that results in better tailored and more effective care.”

Dr. Kapur did not report any relevant disclosures.


 

FROM SLEEP

Patients with obstructive sleep apnea can be grouped into distinct clinical subtypes that differ in response to positive airway pressure treatment, according to two studies published in the March issue of the journal Sleep.

In the first study, investigators evaluated whether patients in different clinical clusters responded differently to positive airway pressure (PAP) treatment. Authors identified 706 patients with moderate to severe obstructive sleep apnea (OSA) from the Icelandic Sleep Apnea Cohort. All patients completed a sleep study prior to starting PAP treatment, and completed questionnaires to assess symptoms. Patients were grouped into one of three clusters based on symptomatology: disturbed sleep, minimally symptomatic, or sleepy, wrote Grace W. Pien, MD, of the division of pulmonary and critical care medicine at Johns Hopkins University, Baltimore, and her coauthors.

Tab1962/iStockphoto.com
PAP adherence was assessed using questionnaires and PAP device memory card data. At the 2 year follow-up, 457 (64.7%) patients reported PAP adherence. Objective adherence measures were available for 351 (76.8%) patients; for the remainder, PAP adherence was determined using self-reported data. Patients in the sleepy cluster were more likely than the other two subtypes to be PAP users at 70.0% usage, compared with 61.1% of those in the disturbed-sleep group and 60.0% in the minimally symptomatic group (P = .034), the authors said in Sleep.

Patients in the minimally symptomatic cluster reported symptoms at lower rates than patients in the other clusters at baseline, and they remained relatively asymptomatic at follow-up, the authors noted. By comparison, patients in the sleepy group reported the highest Epworth Sleepiness Scale scores at baseline (16.0 plus or minus 3.4), which fell by five points at follow-up (mean change, −5.3; 95% confidence interval, −5.8 to −4.8). Also, patients in the sleepy group reported higher rates of drowsy driving (37.8%) at baseline, which dropped to 8.1% at follow-up (odds ratio, 0.06; 95% CI, 0.03-0.14).

Pages

Recommended Reading

Prazosin falls short for veterans’ PTSD-related sleep problems
MDedge Internal Medicine
OSA may provide cardioprotection
MDedge Internal Medicine
OSA patients report sleeping better with dronabinol
MDedge Internal Medicine
CPAP adherence linked to reduced readmissions
MDedge Internal Medicine
Poor sleep, suicide risk linked in college students
MDedge Internal Medicine
Insomnia, major depressive episode linked in U.S. soldiers
MDedge Internal Medicine
OSA may provide cardioprotection
MDedge Internal Medicine
Excessive daytime sleepiness linked to increase in Alzheimer’s biomarker
MDedge Internal Medicine
MDedge Daily News: Why the barber’s chair can help hypertension
MDedge Internal Medicine
Effectiveness, adherence similar for nasal pillows and standard masks
MDedge Internal Medicine